Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01498692 · ClinicalTrials.gov registry record · NA

The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions in Small Vessels

A NA study of Coronary Artery Disease, sponsored by Boston Scientific Corporation.

Completed
Registry status
NA
Development phase
94
Enrollment target
20
Study locations

NCT01498692 is a NA study of Coronary Artery Disease that has completed, run by Boston Scientific Corporation. The registered enrollment target is 94 participants, below the 1,287-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (93% lower). The trial reports 20 study locations across 13 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01498692, a NA study of Coronary Artery Disease, has completed, sponsored by Boston Scientific Corporation.

COMPLETED
Registry status
NA
Development phase
94 participants
Enrollment target
20
Study locations

Study Summary

The purpose of this study is to evaluate the safety and effectiveness of the PROMUS Element™ Everolimus-Eluting Coronary Stent System for the treatment of patients with up to 2 de novo atherosclerotic coronary artery lesions. The lesions can be located in vessels that are smaller than average-sized.

Conditions Studied

Coronary Artery Disease

Interventions

  • DEVICE PROMUS Element Coronary Stent System

Study Locations (20)

Other

  • Monash Medical Centre - Clayton
  • Ziekenhuis Oost Limburg - Genk
  • UZ Gasthuisberg - Leuven
  • Clinique Pasteur - Toulouse

Florida

  • Mediquest Research at Munroe Regional Medical Center - Ocala
  • Florida Hospital - Orlando

North Carolina

  • Moses H. Cone Memorial Hospital/LeBauer Cardiovascular Research Foundation - Greensboro
  • Wake Medical Center - Raleigh

Ohio

  • Lindner Center for Research and Education at The Christ Hospital - Cincinnati
  • Ohio Health Research and Innovation Institute - Columbus

Texas

  • Baylor Heart & Vascular Hospital - Dallas
  • TexSAn Heart Hospital - San Antonio

California

  • Bakersfield Memorial Hospital - Bakersfield

Illinois

  • St. John's Hospital - Springfield

Kentucky

  • Jewish Hospital & St. Mary's Healthcare - Louisville

Trial Details

FieldValue
Enrollment Target 94 participants
Start Date 2009-02
Est. Completion 2015-05
Phase NA

Sponsor

Boston Scientific Corporation

280 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01498692

The ClinicalTrials.gov registry entry for NCT01498692 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 94 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,287-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (93% lower). The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Coronary Artery Disease appearing as the primary indexed condition, and to 1 intervention - of which PROMUS Element Coronary Stent System is the first listed.

NCT01498692 reports 20 study locations spanning 13 distinct geographic areas - top geographies include Other, Florida, North Carolina.

Frequently Asked Questions

What is clinical trial NCT01498692 about?

NCT01498692 is a clinical study titled "The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions in Small Vessels". The purpose of this study is to evaluate the safety and effectiveness of the PROMUS Element™ Everolimus-Eluting Coronary Stent System for the treatment of patients with up to 2 de novo atherosclerotic coronary artery lesions. The lesions can be located in vessels that are smaller than average-sized.

What is the current status of trial NCT01498692?

This trial is currently completed. It is a NA study. The enrollment target is 94 participants. The study started on 2009-02. Estimated completion is 2015-05.

What conditions does trial NCT01498692 study?

This clinical trial studies the following conditions: Coronary Artery Disease.

What interventions are being tested in trial NCT01498692?

The interventions under investigation include: PROMUS Element Coronary Stent System (DEVICE).

Who is sponsoring clinical trial NCT01498692?

This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01498692 being conducted?

This trial has 20 study locations across California, Florida, Illinois, Kentucky, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Coronary Artery Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Coronary Artery Disease

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.